Short Interest in ViaDerma, Inc. (OTCMKTS:VDRM) Declines By 19.9%

ViaDerma, Inc. (OTCMKTS:VDRM) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 99,600 shares, a decline of 19.9% from the January 15th total of 124,300 shares. Based on an average daily volume of 5,158,600 shares, the short-interest ratio is currently 0.0 days.

ViaDerma Trading Up 4.1 %

Shares of ViaDerma stock opened at $0.02 on Friday. ViaDerma has a twelve month low of $0.00 and a twelve month high of $0.02. The business’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01.

About ViaDerma

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.